Trial Profile
Clinical effect of lowering heart rate in sepsis syndromes; comparing ivabradine 10 mg and 15 mg versus placebo.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Multiple organ failure; Sepsis; Septic shock
- Focus Therapeutic Use
- 16 Sep 2016 New trial record